div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: poster a2 toray ol · 2012 1 26 · having specific human leukocyte antigen HLA types Patient-specific iPS cells provide unprecedented opportuni- ties in disease research drug src=https:reader034fdocumentpubreader034viewer20220519075ffa611bb2a10a4a0d6b6501html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: poster a2 toray ol · 2012 1 26 · having specific human leukocyte antigen HLA types Patient-specific iPS cells provide unprecedented opportuni- ties in disease research drug src=https:reader034fdocumentpubreader034viewer20220519075ffa611bb2a10a4a0d6b6501html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: poster a2 toray ol · 2012 1 26 · having specific human leukocyte antigen HLA types Patient-specific iPS cells provide unprecedented opportuni- ties in disease research drug src=https:reader034fdocumentpubreader034viewer20220519075ffa611bb2a10a4a0d6b6501html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: poster a2 toray ol · 2012 1 26 · having specific human leukocyte antigen HLA types Patient-specific iPS cells provide unprecedented opportuni- ties in disease research drug src=https:reader034fdocumentpubreader034viewer20220519075ffa611bb2a10a4a0d6b6501html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: poster a2 toray ol · 2012 1 26 · having specific human leukocyte antigen HLA types Patient-specific iPS cells provide unprecedented opportuni- ties in disease research drug...